RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives
Authors
Keywords
-
Journal
BIOESSAYS
Volume 38, Issue 4, Pages 344-354
Publisher
Wiley
Online
2016-01-28
DOI
10.1002/bies.201500118
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intrathecal RGS4 Inhibitor, CCG50014, Reduces Nociceptive Responses and Enhances Opioid-Mediated Analgesic Effects in the Mouse Formalin Test
- (2015) Seo-Yeon Yoon et al. ANESTHESIA AND ANALGESIA
- Regulator of G-protein signalling 5 protects against atherosclerosis in apolipoprotein E-deficient mice
- (2015) Wen-Lin Cheng et al. BRITISH JOURNAL OF PHARMACOLOGY
- RGS2 and RGS4 proteins: New modulators of the κ-opioid receptor signaling
- (2015) Maria-Pagona Papakonstantinou et al. CELLULAR SIGNALLING
- An Essential Role for RGS Protein/Gαi2Interactions in B Lymphocyte–Directed Cell Migration and Trafficking
- (2015) Il-Young Hwang et al. JOURNAL OF IMMUNOLOGY
- RGS4 inhibits angiotensin II signaling and macrophage localization during renal reperfusion injury independent of vasospasm
- (2015) Paul Pang et al. KIDNEY INTERNATIONAL
- Epidemiology of inflammatory bowel disease: Focus on Asia
- (2014) Siew C. Ng BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Novel orally available salvinorin A analog PR-38 protects against experimental colitis and reduces abdominal pain in mice by interaction with opioid and cannabinoid receptors
- (2014) Maciej Sałaga et al. BIOCHEMICAL PHARMACOLOGY
- Regulator of G-protein signaling 6 (RGS6) promotes anxiety and depression by attenuating serotonin-mediated activation of the 5-HT1A receptor-adenylyl cyclase axis
- (2014) Adele Stewart et al. FASEB JOURNAL
- Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH)
- (2014) M. Sałaga et al. Journal of Crohns & Colitis
- RGS13 Controls G Protein-Coupled Receptor-Evoked Responses of Human Mast Cells
- (2014) G. Bansal et al. JOURNAL OF IMMUNOLOGY
- Vagal anandamide signaling via cannabinoid receptor 1 contributes to luminal 5-HT modulation of visceral nociception in rats
- (2014) Chen-Chen Feng et al. PAIN
- Anti-inflammatory action of a novel orally available peptide 317 in mouse models of inflammatory bowel diseases
- (2014) Marta Sobczak et al. Pharmacological Reports
- Vedolizumab for inflammatory bowel disease: Changing the game, or more of the same?
- (2014) Tim Raine United European Gastroenterology Journal
- Effect of Ramosetron on Stool Consistency in Male Patients With Irritable Bowel Syndrome With Diarrhea
- (2013) Shin Fukudo et al. Clinical Gastroenterology and Hepatology
- Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine
- (2013) Kara Gross Margolis et al. GUT
- A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea
- (2013) Klara Garsed et al. GUT
- RGS6, but Not RGS4, Is the Dominant Regulator of G Protein Signaling (RGS) Modulator of the Parasympathetic Regulation of Mouse Heart Rate
- (2013) Nicole Wydeven et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives
- (2013) Marta Sobczak et al. JOURNAL OF GASTROENTEROLOGY
- Serotonin signalling in the gut—functions, dysfunctions and therapeutic targets
- (2013) Gary M. Mawe et al. Nature Reviews Gastroenterology & Hepatology
- Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS
- (2012) F. Cremonini et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A finer tuning of G-protein signaling through regulated control of RGS proteins
- (2012) Jacob Kach et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Brain-Gut Interactions in Inflammatory Bowel Disease
- (2012) Bruno L. Bonaz et al. GASTROENTEROLOGY
- RGS16 Attenuates Pulmonary Th2/Th17 Inflammatory Responses
- (2012) S. P. Shankar et al. JOURNAL OF IMMUNOLOGY
- The Loss of RGS Protein-G i2 Interactions Results in Markedly Impaired Mouse Neutrophil Trafficking to Inflammatory Sites
- (2012) H. Cho et al. MOLECULAR AND CELLULAR BIOLOGY
- The Complex of G Protein Regulator RGS9-2 and G 5 Controls Sensitization and Signaling Kinetics of Type 5 Adenylyl Cyclase in the Striatum
- (2012) K. Xie et al. Science Signaling
- RGS proteins in heart: brakes on the vagus
- (2012) Adele Stewart Frontiers in Physiology
- Serotonin Activates Dendritic Cell Function in the Context of Gut Inflammation
- (2011) Nan Li et al. AMERICAN JOURNAL OF PATHOLOGY
- A Nanomolar-Potency Small Molecule Inhibitor of Regulator of G-Protein Signaling Proteins
- (2011) Levi L. Blazer et al. BIOCHEMISTRY
- Localization and Regulation of Fluorescently Labeled Delta Opioid Receptor, Expressed in Enteric Neurons of Mice
- (2011) Daniel P. Poole et al. GASTROENTEROLOGY
- Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors*
- (2011) Jakub Fichna et al. INFLAMMATORY BOWEL DISEASES
- Cutting Edge: Regulator of G Protein Signaling-1 Selectively Regulates Gut T Cell Trafficking and Colitic Potential
- (2011) D. L. Gibbons et al. JOURNAL OF IMMUNOLOGY
- A Unique Role of RGS9-2 in the Striatum as a Positive or Negative Regulator of Opiate Analgesia
- (2011) K. Psigfogeorgou et al. JOURNAL OF NEUROSCIENCE
- Impact of fusion to Gαi2and co-expression with RGS proteins on pharmacological properties of human cannabinoid receptors CB1R and CB2R
- (2011) Sarah Sutor et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease
- (2011) A Di Sabatino et al. Mucosal Immunology
- R7BP Modulates Opiate Analgesia and Tolerance but not Withdrawal
- (2011) Dimitra Terzi et al. NEUROPSYCHOPHARMACOLOGY
- Regulators of G-Protein Signaling and Their G Substrates: Promises and Challenges in Their Use as Drug Discovery Targets
- (2011) A. J. Kimple et al. PHARMACOLOGICAL REVIEWS
- SUMO-SIM Interactions Regulate the Activity of RGSZ2 Proteins
- (2011) Javier Garzón et al. PLoS One
- Gβ5-RGS complexes are gatekeepers of hyperactivity involved in control of multiple neurotransmitter systems
- (2011) Keqiang Xie et al. PSYCHOPHARMACOLOGY
- Small Molecule Inhibitors of Regulators of G Protein Signaling (RGS) Proteins
- (2011) Emma M. Turner et al. ACS Medicinal Chemistry Letters
- Non-canonical functions of RGS proteins
- (2010) Nan Sethakorn et al. CELLULAR SIGNALLING
- RGS6/Gβ5 Complex Accelerates I KACh Gating Kinetics in Atrial Myocytes and Modulates Parasympathetic Regulation of Heart Rate
- (2010) Ekaterina Posokhova et al. CIRCULATION RESEARCH
- RGS6, a Modulator of Parasympathetic Activation in Heart
- (2010) Jianqi Yang et al. CIRCULATION RESEARCH
- Thinking Outside of the "RGS Box": New Approaches to Therapeutic Targeting of Regulators of G Protein Signaling
- (2010) B. Sjogren et al. MOLECULAR PHARMACOLOGY
- Allosteric Inhibition of the Regulator of G Protein Signaling-G Protein-Protein Interaction by CCG-4986
- (2010) D. L. Roman et al. MOLECULAR PHARMACOLOGY
- Reversible, Allosteric Small-Molecule Inhibitors of Regulator of G Protein Signaling Proteins
- (2010) L. L. Blazer et al. MOLECULAR PHARMACOLOGY
- Cannabinoids and the gut: New developments and emerging concepts
- (2010) Angelo A. Izzo et al. PHARMACOLOGY & THERAPEUTICS
- RGS16 Is a Marker for Prognosis in Colorectal Cancer
- (2009) Norikatsu Miyoshi et al. ANNALS OF SURGICAL ONCOLOGY
- Regulator of G protein signaling 4 confers selectivity to specific G proteins to modulate μ- and δ-opioid receptor signaling
- (2009) Leonidas J. Leontiadis et al. CELLULAR SIGNALLING
- Serotonin Has a Key Role in Pathogenesis of Experimental Colitis
- (2009) Jean–Eric Ghia et al. GASTROENTEROLOGY
- Cloning and characterization of rabbit Rgs4 promoter in gut smooth muscle
- (2009) Fang Li et al. GENE
- Differential Modulation of μ- and δ-Opioid Receptor Agonists by Endogenous RGS4 Protein in SH-SY5Y Cells
- (2009) Qin Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Differential modulation of mu-opioid receptor signaling to adenylyl cyclase by regulators of G protein signaling proteins 4 or 8 and 7 in permeabilised C6 cells is Gα subtype dependent
- (2009) Jeffery N. Talbot et al. JOURNAL OF NEUROCHEMISTRY
- A covalent peptide inhibitor of RGS4 identified in a focused one-bead, one compound library screen
- (2009) Rebecca A Roof et al. BMC Pharmacology & Toxicology
- Interleukin-1β up-regulates RGS4 through the canonical IKK2/IκBα/NF-κB pathway in rabbit colonic smooth muscle
- (2008) Wenhui Hu et al. BIOCHEMICAL JOURNAL
- RGS4 Regulates Parasympathetic Signaling and Heart Rate Control in the Sinoatrial Node
- (2008) Carlo Cifelli et al. CIRCULATION RESEARCH
- Regulators of G-protein signalling are modulated by bacterial lipopeptides and lipopolysaccharide
- (2008) Sabine Riekenberg et al. FEBS Journal
- Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors
- (2008) Martin A. Storr et al. JOURNAL OF MOLECULAR MEDICINE-JMM
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started